OmniAb Inc. (OABI): Stock Price, Earnings & Key Metrics

Price

$4.45

return (12m)

177.81%

p/e

-13.56

p/bv

2.31

DIVIDEND YIELD

0.00%

OABI price

OmniAb Inc.

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment OABI

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

123.37%

3 months

70.31%

1 year

177.81%

2 years

4.10%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals OABI

Valuation

P/E

-13.56

Sector -4.26

Industry -4.26

P/BV

2.31

Sector 2.11

Industry 2.11

P/Revenue (PSR)

15.62

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

-15.96

Sector -50.76

Industry -50.76

P/EBIT

-9.77

Sector -39.62

Industry -39.62

P/Total Assets

2.07

Sector 1.25

Industry 1.25

P/Net Current Assets

16.66

Sector -5.47

Industry -5.47

P/Working Capital

11.49

Sector -1.10

Industry -1.10

EPS

-0.34

Sector -1.94

Industry -1.94

BVPS

2.02

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

50.53%

Sector 38.90%

Industry 38.90%

EBITDA Margin

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

-31.44%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

-100.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

-100.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.05

Sector 0.03

Industry 0.03

Profitability

ROE

-17.01%

Sector -61.50%

Industry -61.50%

ROA

-15.25%

Sector -63.85%

Industry -63.85%

ROIC

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.80

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

Sector -0.60

Industry -0.60

Gross Debt / Equity

Sector -0.83

Industry -0.83

Equity/Assets

0.90

Sector 0.43

Industry 0.43

Liabilities/Assets

0.10

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

2.64%

Sector -

Industry -

5Y Earnings CAGR

10.06%

Sector -

Industry -

Fundamentals OABI

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
OABI OmniAb Inc.	$4.45	171.04%	0.00%	-13.56	2.31	-17.01%	-100.00%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

OABI Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT OmniAb Inc.

OmniAb Inc.

Average Investor10 user rating

4.0 (0 people)

United States

14 years

Founded: 2012

2022

Time since IPO - 4 years

11.100

Employees

OmniAb Inc. (United States) is listed on the Nasdaq and has a market capitalization of $600.18 million, with shareholders equity totaling $260.27 million.

The company employs approximately 11.100 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, OmniAb Inc. reported $38.43 million in revenue, generating net income of $-44.27 million.

Key financial metrics include a P/E ratio of -13.56, a price-to-book (P/B) ratio of 2.31, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker OABI.

Market cap

$600.18 million

Net worth

$260.27 million

$260,274,000.00

Assets

$290.26 million

$290,257,000.00

Total Shares Outstanding

128.80 million

128,795,000

Average Daily Trading Volume

$783.80 Thousand

$783,796.00

Sector

Health Care

Industry

Biotechnology

OABI

OABI revenue and profits

Financial Results OABI

DRAG THE FRAME TO SEE MORE DATA

OABI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of OmniAb Inc. (OABI) today?

A cotação de OmniAb Inc. (OABI) hoje está em US$ 4.45, com uma variação de 177.81% em relação ao último ano. A cotação de OmniAb Inc. (OABI) iniciou o ano negociando na casa dos US$ 1.88 e hoje está em US$ 4.45. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de OmniAb Inc. (OABI) e dados de ações do Ibovespa e mercados internacionais.

Quando OmniAb Inc. (OABI) paga dividendos?

OmniAb Inc. (OABI) não distribuiu dividendos no último ano.

Is OmniAb Inc. (OABI) a good investment?

Atualmente, OmniAb Inc. (OABI) está cotada a US$ 4.45, com um P/L de -13.56, representando um desvio de -1,713% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 177.81 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 177.81%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy OmniAb Inc. (OABI) stock?

Investir em ações de OmniAb Inc. (OABI) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of OmniAb Inc. (OABI) yield today?

A rentabilidade de OmniAb Inc. (OABI) foi de 123.37% no último mês, 177.81% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de OmniAb Inc. (OABI) hoje, o investimento total seria de US$ 444.50, com base na cotação atual de US$ 4.45.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,234.87
Em 5 anos: US$ 444.50
Em 10 anos: US$ 444.50

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

OABI

OmniAb Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment OABI

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING OABI WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT OmniAb Inc.

OmniAb Inc.

United States

14 years

2022

11.100

PROFIT X PRICE OABI

Financial Results OABI

OABI cash flow

Asset, Revenue and Profit Growth - OABI

OABI balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions